Squarepoint’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
2023
Q4
$126K Sell
2023
Q3
$274K Buy
2023
Q2
$86.1K Buy
2022
Q3
Sell
2022
Q2
$102K Sell
2022
Q1
$216K Sell
2021
Q4
$606K Buy
2021
Q1
Sell
2020
Q4
$1.48M Sell
2020
Q3
$1.63M Buy